News about Biotechnology, Pharmaceutical and Healthcare

22:20 EDT 22nd September 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 8,800+

Monday 22nd September 2014

Campaigners urge for HPV vaccine to be extended to boys

Public health experts are meeting today to discuss whether boys as well as girls should be offered the HPV jab. The consultation follows the publication of a paper from The Royal Society for Public Health (RSPH) calling for an extension of the vaccines to be available to both sexes. It is thought that vaccinating girls early will reduce the number of men eventually getting HPV because infection oc...

Patients struggling to take conventional medicines

A new survey commissioned by Hermes Pharma, which develops easier-to-swallow pills, has found that more than half of those asked had difficulties swallowing tablets and that new drugs need to be personalised. The study was conducted by Spiegel Institut Mannheim and targeted 1,000 people in both the US and Germany. Key findings include: read more

Merck KGaA pays out $17 billion for Sigma-Aldrich

Merck KGaA has swooped in and bought US-based Sigma-Aldrich in a deal worth $17 billion (€13.1 billion). The acquisition will help shore up Merck’s Millipore lab supplies business, as Missouri-based Sigma-Aldrich is the world’s largest supplier of biochemicals and organic chemicals to research laboratories. The company saw sales of $2.7 billion last year and was attractive enough to see Merc...

Industry-first glycolipid-specific library

Identifies 256 types of glycolipids with LCMS-IT-TOF / Precise analysis of entire glycolipid structure / Supports high precision analysis in various fields  Shimadzu, one of the world leaders in analytical instrumentation, has released the industry-first glycolipid-specific library, containing information on 256 types of glycolipids. The library is a result of joint research with Dr. Akemi Su...

Merck to Acquire Sigma-Aldrich to Enhance Position in Attractive Life Science Industry

Merck and Sigma-Aldrich today announced that they have entered into a definitive agreement under which Merck will acquire Sigma-Aldrich for $17.0 billion (€13.1 billion), establishing one of the leading players in the $130 billion global life science industry. Merck will acquire all of the outstanding shares of Sigma-Aldrich for $140 per share in cash. The agreed price represents a 37% prem...

Half of cancers diagnosed at late stage

A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an advanced stage, when they are harder to treat successfully. The figures come as a new report also out this week shows that if the whole of the NHS in England diagnosed cancers as early as those areas known to be the best, then this could save the NHS over £44 million in treatment costs – ...

WHO statement on the second meeting of the International Health Regulations Emergency Committee regarding the 2014 Ebola outbreak in west Africa

The second meeting of the Emergency Committee convened by the WHO Director-General under the IHR 2005 regarding the 2014 Ebola virus disease (EVD, or “Ebola”) outbreak in west Africa was conducted with members and advisors of the Emergency Committee through electronic correspondence from 16 September 2014 through 21 September 20141. The following IHR States Parties provided an update on and...

Pharmarama International Limited relaunches as Alium Medical

Published date:  22/09/2014 Summary:  Pharmarama International Limited relaunches as Alium Medical read more

Gilead’s blood cancer pill approved in Europe

Gilead has gained European Commission approval for its new blood cancer pill Zydelig (idelalisib) as it looks to expand further into oncology. Zydelig is a first-in-class oral treatment for two incurable blood cancers, namely: chronic lymphocytic leukaemia (CLL) and follicular lymphoma (FL). For the treatment of CLL, Zydelig has been approved for use in combination with Roche’s arthritis and can...

Sherwood Scientific help manufacturers monitor their salt content

Salt content of foods is receiving increasing attention and there is now a move towards a significant reduction in dietary salt.  Monitoring sodium concentrations in food ingredients and final product is a universal requirement. The most sensitive and robust technique has always been flame photometry. Sherwood Scientific has introduced two new products, which allows the busy analyst to autom...

Bigger Capacity Benchtop Autoclave Meets Customer Wish List

The Priorclave H60 compact autoclave, designed specifically to meet a customer requirement for a steam steriliser with all the proven strengths and features of the current Priorclave Compact range but with a 50% increase in chamber capacity, is now part of the Companies standard range of benchtop autoclaves. Despite having the most comprehensive range of laboratory autoclaves there is always someo...

Phenom-World release new PoroMetric Software

Designed especially for the Phenom Desktop SEM PoroMetric Software for Fully Automated Measurement and Analysis of Pores The visualization and analysis of pores is easier than ever before with the Phenom desktop SEM and the PoroMetric software. The combination of speed, ease of use and superb imaging quality of the Phenom and image pore analysis software of PoroMetric creates a powerful tool for i...

Automated Microplate Drying Workstation

£1000 trade-in value on any evaporator system against the purchase of a new UltraVap Mistral The UltraVap Mistral from Porvair Sciences makes it easy to integrate an automatic dry down step into your automated liquid handling protocol. Optimised to work with most commercial robotic liquid handling systems the UltraVap Mistral represents the leading edge in automated ...

Tecan and RECIPE announce co-marketing agreement for automation of LC-MSMS IVD kits

With clinical laboratories increasingly turning to high throughput LC-MSMS analysis, laboratory automation specialist Tecan and RECIPE Chemicals and Instruments GmbH, a leading manufacturer of IVD/CE diagnostic products, have announced a co-marketing agreement for automation of LC-MSMS IVD kits. Visitors to Booth #1 at MSACL 2014 EU in Salzburg, Austria, from the 2nd to the 5th of September, had t...

Sunday 21st September 2014

Laboratoris Rubió, committed to research, acquires 30% of Biosfer Teslab biotech firm

The two companies will co-develop a cardiovascular diagnostic test

Chemical entrepreneurs of Europe meet at ChemUp

Esade, Sequi and Expoquimia are promoting this initiative to boost entrepreneurial innovation in the field of chemistry

Kick-off of European Institute of Innovation and Technology (EIT) KIC in health

Biocat, along with the University of Barcelona, has promoted and coordinated the proposal

Relationship between environment and child brain development, one of great challenges in neuroscience

B·Debate and CREAL are organizing a scientific debate with national and international experts on 16 and 17 October

Second session in “Lessons Learned” series to deal with international public finance

CataloniaBIO and Biocat are promoting this initiative to foster knowledge and networking among professionals

Biocat takes debate on how to accelerate innovative start-ups to Biospain 2014

Biocat will also participate in the session promoted by Transbio Sudoe on scientific collaboration and transfer

Saturday 20th September 2014

Microvisk News: CE Mark for "World First" Medical Device

Solid state technology unique in medical diagnosticsMedical device innovator Microvisk Ltd. has achieved CE marking for healthcare professional use of the world’s first disposable medical diagnostic strip based on a Micro-Electro-Mechanical Sys...

Cambridge Research Biochemicals' Official Opening Ceremony

The Gardner Ratcliffe Building – Official OpeningOn Wednesday 17th September, leading British custom peptide and antibody provider Cambridge Research Biochemicals welcomed guests to 'the Gardner Ratcliffe Building' for its prestigious Official Open...

Friday 19th September 2014

Concerns from EU and US over Colombian biologicals guidelines

On 21 January 2013, the Colombian Ministry of Health and Social Protection (Ministerio de Salud y Protección Social de Colombia) released a new draft guideline for biologicals, including 'productos bioterapéuticos similares' (similar biothera...

Biosimilars of trastuzumab

Trastuzumab is a monoclonal antibody that interferes with the human epidermal growth factor receptor 2 (HER2)/neu receptor. In some cancers, notably certain types of breast cancer, HER2 is over-expressed, and causes cancer cells to reproduce uncontro...

Pegfilgrastim biosimilar approved in South Korea

South Korean biologicals company, Green Cross, announced on 18 August 2014 that it had received marketing authorization from South Korea’s Ministry of Food and Drug Safety for its pegfilgrastim biosimilar Neulapeg.

Search BioPortfolio: